Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

Multiple Sclerosis

Volumn 21, Issue 13, 2015, Pages 1723-1729

  Voldsgaard, A ^a   Bager, P ^b   Garde, E ^c   Akeson P ^c   Leffers, A M ^c   Madsen, C G ^c   Kapel, C ^d   Roepstorff, A ^d   Thamsborg, S M ^d   Melbye, M ^b   Siebner, H ^c   Sondergaard H B ^a   Sellebjerg, F ^a   Sørensen, P Soelberg ^a  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

helminths; MRI; multiple sclerosis; safety; Trichuris suis ova; TSO

Indexed keywords

BETA INTERFERON; GADOLINIUM; NATURAL PRODUCT;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHILIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLATULENCE; GENE EXPRESSION; HUMAN; MALE; MARKER GENE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TRICHURIS SUIS; WORM EGG; ADVERSE EFFECTS; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GASTROINTESTINAL TRACT; IMMUNOLOGY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PARASITOLOGY; PHASE 2 CLINICAL TRIAL; PROCEDURES; RECURRENT DISEASE; THERAPY WITH HELMINTHS; TRICHURIS; YOUNG ADULT;

ADULT; ANIMALS; DISEASE PROGRESSION; EOSINOPHILIA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; THERAPY WITH HELMINTHS; TRICHURIS; YOUNG ADULT;

EID: 84937247769     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514568173     Document Type: Article

References (20)

1. Poser S, Stickel B, Krtsch U, et al. Increasing incidence of multiple sclerosis in South Lower Saxony, Germany. Neuroepidemiology 1989; 8 (4): 207-213.
2. EURODIAB ACE,. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355 (9207): 873-876.
3. Swarbrick ET, Farrokhyar F, Irvine EJ,. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001; 36: 2-15
4. Fleming JO, Cook TD,. Multiple sclerosis and the hygiene hypothesis. Neurology 2006; 67 (11): 2085-2086.
5. Summers RW, Elliott DE, Urban JF Jr, et al. Trichuris suis therapy in Crohn's disease. Gut 2005; 54 (1), 87-90.
6. Summers RW, Elliott DE, Weinstock JV, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128 (4), 825-832.
7. Sewell D, Qing Z, Fabry Z, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15 (1), 59-69.
8. La Flamme AC, Ruddenklau K, Backstrom BT,. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003; 71 (9), 4996-5004.
9. Correale J, Farez M,. Association between parasite infections and immune responses in multiple sclerosis. Ann Neurol 2007; 61: 97-108.
10. Correale J, Farez M,. Helminth-infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008; 64: 187-199.
11. Fleming JO, Isaak A, Fabry Z, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: A phase 1 study. Multiple Sclerosis 2011; 17 (6): 743-754.
12. Benzel F, Erdur H, Rosche B, et al. Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients. J Helminthology 2012; 86 (3): 339-347.
13. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25 (4): 402-408.
14. Hesse D, Krakauer M, Sellebjerg F, et al. Breathrough disease during interferon-(beta) therapy in MS: No signs of impaired biologic response. Neurology 2010 4; 74 (18): 1455-1462.
15. Hesse D, Krakauer M, Sellebjerg F, et al. Disease protection and interleukin-10 induction by endogenous interferon-b in multiple sclerosis? Eur J Neurol 2011; 18 (2): 266-272.
16. Molyneux PD, Filippi M, Miller DH, et al. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 1998; 43 (3): 332-339.
17. Bager P, Arnved J, Melbye M, et al. Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 2010; 125: 123-130.
18. Bourke CD, Mutapi F, Nausch N, et al. Trichuris suis ova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response. Clin Exp Allergy 2012; 42 (11): 1582-1595.
19. Bager P, Kapel C, Roepstorff A, et al. Symptoms after ingestion of pig whipworm Trichuris suis eggs in a randomized placebo-controlled double-blind clinical trial. PLoS One 2011; 6 (8): e22346.
20. Rosche B, Wernecke KD, Ohlraun S, Dörr JM, Paul F,. Trichuris suis ova in relapsing-remitting multiple sclerosis and clinical isolated syndrome (TRIOMS): Study protocol for a randomized controlled trial. Trials 2013 25; 14: 112.